Global Commission on Drug Policy

Last updated

The Global Commission on Drug Policy (GCDP) is a panel of world leaders and intellectuals, with a Secretariat based in Geneva, Switzerland. [1]

Contents

In June 2011, the commission said: "The global war on drugs has failed, with devastating consequences for individuals and societies around the world." [2] The emphasis in drug policy on harsh law enforcement over four decades has not accomplished its goal of banishing drugs and has in fact spawned wide, dramatic eruptions of violence, the report continued. By way of alternative, the GCDP report "advocates decriminalizing drug use by those who do no harm to others." [3]

The commission was formed to "bring to the international level an informed, science-based discussion about humane and effective ways to reduce the harm caused by drugs to people and societies. [It built] on the experience of the Latin American Commission on Drugs and Democracy" [4] [5] and extended to West Africa in 2013–14 via an initiative of GCPD board member and former UN Secretary General Kofi Annan and the West Africa Commission on Drugs. [6]

At year-end 2017, GCDP board member George Shultz and economist and former secretary of finance in Mexico Pedro Aspe reaffirmed the message of the commission in a New York Times op-ed. [7]

The Commission has been successively chaired by Fernando Henrique Cardoso, the former President of Brazil, Ruth Dreifuss, former President of Switzerland, and Helen Clark, former Prime Minister of New Zealand. The Secretariat handles the daily operations of the Commission under the leadership of its director, Khalid Tinasti.

Membership

Members of the Global Commission on Drug Policy: [8]

Former members

Reactions to the 2011 report Archived 2018-01-18 at the Wayback Machine

Immediate

Gabor Maté, a Hungarian-Canadian physician who specializes in study and treatment of addiction, was interviewed on Democracy Now! about the report. [10]

Former U.S. President Jimmy Carter wrote an op-ed in The New York Times explicitly endorsing the recommendations of the commission, saying they were in line with the policies of his administration; and saying it was the policies of the succeeding Reagan administration which had moved U.S. policy so far toward punitive alternatives. [11] Carter's piece elicited several published responses, including one from an analyst for Common Sense for Drug Policy who drew attention to the current White House Office of National Drug Control Policy's immediate rejection of GCDP's recommendations and defense of the "balanced drug control efforts" of the U.S. federal government; and others which agreed and disagreed with Carter's views. [12]

Brian Lehrer had Ethan Nadelmann, founder and director of the Drug Policy Alliance, on Lehrer's radio show to detail the GCDP report and how that might impact U.S. anti-drug policies. [13]

Sir Ronald Sanders, a consultant and former Caribbean diplomat, wrote in favor of the recommendations and endorsement of President Carter's expressed views. [14]

Extended

Peter Hakim prominently cited the GCDP report in an October, 2011, "rethinking [of] U.S. drug policy". [15]

The Beckley Foundation's Global Initiative for Drug Policy Reform antedated the release of the GCDP report but integrated the GCPD into its November, 2011, British House of Lords meetings. Professor Robin Room (University of Melbourne [16] ) was preparing a "Rewriting the UN Drug Conventions Report" based on amendments to the UN drug control conventions of 1961, 1971 and 1988 for the Initiative; and Professor Stephen Pudney (Institute for Social and Economic Research) was preparing "the first-ever Cost-benefit Analysis of the control of cannabis through regulation and taxation in the UK" for it. [17] Amanda Feilding of the Foundation and other peers led the effort [18] and attracted some criticism for it.[ citation needed ]

Background papers

as of 2011-11-25 [19]

2014 Report - Taking Control: Pathways to Drug Policies That Work Archived 2018-01-18 at the Wayback Machine

On September 9, 2014, the Commission issued its new report, Taking Control: Pathways to Drug Policies that Work. [20] "The report reflects the evolution in the thinking of the Commissioners, who reiterate their demands for decriminalization, alternatives to incarceration, and greater emphasis on public health approaches and now also call for permitting the legal regulation of psychoactive substances. The Commission is the most distinguished group of high-level leaders to ever call for such far-reaching changes." [21]

Disappointment with UNGASS 2016

In April 2016, the GCDP reacted to the United Nations General Assembly Special Session (UNGASS) drug conference, saying the commission was "profoundly disappointed with the adopted outcome document". [22] The Wall Street Journal lumped the attendees' positions "somewhat" in two camps: "Some European and South American countries as well as the U.S. favored softer approaches. Eastern countries such as China and Russia and most Muslim nations like Iran, Indonesia and Pakistan remained staunchly opposed." Mexican President Enrique Peña Nieto said “We must move beyond prohibition to effective prevention” and that Mexico was considering legalizing medical marijuana and limited decriminalization of the drug. GCDP member Branson was quoted as saying the conference outcome was "out of step with world sentiment and doubles down on status quo”. [23]

2016 Report - Advancing Drug Policy Reform: A New Approach to Decriminalization Archived 2016-11-30 at the Wayback Machine

In November 2016 GCDP released the report, Advancing Drug Policy Reform: a new approach to decriminalization. [24]

Commission Chair Dreifuss said about the report:

After years of denouncing the dramatic effects of prohibition and the criminalization of people that do no harm but use drugs on the society as a whole, it is time to highlight the benefits of well-designed and well-implemented people-centered drug policies. These innovative policies cannot exist as long as we do not discuss, honestly, the major policy error made in the past, which is the criminalization of personal consumption or possession of illicit psychoactive substances in national laws. [1]

Position Paper - The Opioid Crisis in North America Archived 2019-11-05 at the Wayback Machine

On 2 October 2017, the Global Commission published a position paper on the opioid crisis in North America. [25] This opioid-driven public health crisis has reached alarming proportions, contributing in 2016 to an estimated 64,000 deaths from drug overdoses in the US, and some 2,500 in Canada. The members of the Global Commission on Drug Policy, several of whom faced similar crises while occupying the highest levels of government in their own countries, share in this position paper their views and recommendations on how to mitigate this epidemic.

2017 Report - The World Drug Perception Problem: Countering Prejudices About People Who Use Drugs Archived 2018-01-18 at the Wayback Machine

While previous reports by the Global Commission on Drug Policy showed how the potential harms of drugs for people and communities are exacerbated by repressive drug control policies at local, national and international levels, the Global Commission's 2017 report, "The World Drug Perception Problem - Countering Prejudices About People Who Use Drugs" [26] focuses on how current perceptions of drugs and people who use them feed into and off prohibitionist policies. Indeed, drug policy reforms have been difficult to design, legislate or implement because current policies and responses are often based on perceptions and passionate beliefs, and what should be factual discussions leading to effective policies are frequently treated as moral debates. The present report aims to analyze the most common perceptions and fears, contrast them with available evidence on drugs and the people who use them, and provides recommendations on changes that must be enacted to support reforms toward more effective drug policies.

Position Paper - Drug Policy and The Sustainable Development Agenda Archived 2018-09-21 at the Wayback Machine

The Sustainable Development Goals and Agenda 2030 are meant to be a transformational agenda to eradicate poverty, achieve gender equity or save the planet through their implementation. This implementation, based on coherent public policies, is still lacking at the national, regional and international levels. This is most visible in drug policy, where voices from health, human rights and science call for reform, while most countries continue to privilege ideology through law-enforcement and militarization.

The members of the Global Commission on Drug Policy draw from their experience at the highest policy and political levels to provide an analysis of how - beyond powerful words and slogans - sustainable development is impeded by drug control while providing a single, groundbreaking recommendation to address this situation.

2018 Report - Regulation: The Responsible Control of Drugs Archived 2019-11-05 at the Wayback Machine

The Global Commission on Drug Policy released its 2018 report on the responsible control of drugs in Mexico City. The report examined in detail how governments can take control of currently illegal drug markets through responsible regulation, thereby weakening criminal organizations that now profit from the illegal markets.

The new report provided a roadmap for transitioning from illegal to legally regulated drug markets. It offered answers regarding the organizational capacity of state institutions to regulate and control a legal market of potentially dangerous products. It highlighted the challenges facing impoverished populations that constitute the “working class” of the illegal drug markets. It offered possible ways forward to deal with the risks inherent to the resilience of organized crime. Finally, this report called for a reform of the prohibition-based international drug control system, which is compromising a universal and holistic approach to the “drug problem”. [27]

Position Paper - Drug Policy and Deprivation of Liberty Archived 2019-11-05 at the Wayback Machine

This paper shows how the deprivation of liberty for non-violent drug crimes is a wrong and ineffective response, notably because it does not take into account the social and psychological root causes of drug consumption, nor does it consider the economic and social marginalization of low-level actors in the trade. Furthermore, people who are incarcerated are vulnerable, exposed to risks, particularly health risks, for which they are not well-equipped and do not receive adequate care.

In this report, members of the Global Commission on Drug Policy analyze the last thirty years of over incarceration in closed settings, from prisons to migrant administrative detention and from mandatory treatment to private rehabilitation centers. The paper highlights the responsibility of the State towards people who are incarcerated, and demonstrates how their health and well-being are at risk.

2019 Report - Classification of Psychoactive Substances: When Science Was Left Behind Archived 2019-11-05 at the Wayback Machine

In Classification of Drugs: when science was left behind, the Global Commission on Drug Policy explains how the biased historical classification of psychoactive substances has contributed to the "world drug problem". It is the first-ever comprehensive report providing a political reading of the current evaluation and classification, or "scheduling" of drugs according to their harms.

Psychoactive substances should be classified with regard to their potential for dependence and other harms. This is not the case today, where some substances are legally available because they are considered beneficial (medicines) or culturally important (alcohol), while others are seen as destructive, and are strictly prohibited. The classification of drugs is at the core of the international drug control system. As such, governments must ensure that such a classification is pragmatic and based on science and evidence, makes clear the benefits and harms of drugs, and allows for responsible legal regulatory models to control drugs.

Related Research Articles

<span class="mw-page-title-main">Drug policy of the Netherlands</span>

While recreational use, possession and trade of non-medicinal drugs described by the Opium Law are all technically illegal under Dutch law, official policy since the late 20th century has been to openly tolerate all recreational use while tolerating possession and trade under certain circumstances. This pragmatic approach was motivated by the idea that a drug-free Dutch society is unrealistic and unattainable, and efforts would be better spent trying to minimize harm caused by recreational drug use. As a result of this gedoogbeleid, the Netherlands is typically seen as much more tolerant of drugs than most other countries.

<span class="mw-page-title-main">Drug prohibition</span> History, effects and enforcement of the prohibition of drugs

The prohibition of drugs through sumptuary legislation or religious law is a common means of attempting to prevent the recreational use of certain intoxicating substances.

Students for Sensible Drug Policy (SSDP) is an international nonprofit organization advocacy and education organization with focus on drug policy, war on drugs, marijuana legalization, psychedelics, juvenile justice and youth rights, drug decriminalization, criminal justice reform. SSDP promotes global youth civic engagement as a tool in reforming drug policy.

<span class="mw-page-title-main">War on drugs</span> Global anti-drug campaign led by the United States

The war on drugs is the policy of a global campaign, led by the United States federal government, of drug prohibition, military aid, and military intervention, with the aim of reducing the illegal drug trade in the United States. The initiative includes a set of drug policies that are intended to discourage the production, distribution, and consumption of psychoactive drugs that the participating governments, through United Nations treaties, have made illegal.

Commonly-cited arguments for and against the prohibition of drugs include the following:

<span class="mw-page-title-main">Removal of cannabis from Schedule I of the Controlled Substances Act</span> Proposed changes to the legal status of cannabis in U.S. federal law

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act, the category reserved for drugs that have "no currently accepted medical use", is a proposed legal and administrative change in cannabis-related law at the federal level. After being proposed repeatedly since 1972, in 2024, the US Department of Justice announced it was initiating rulemaking to reschedule cannabis to Schedule III of the Controlled Substances Act.

<span class="mw-page-title-main">Single Convention on Narcotic Drugs</span> 1961 international treaty regulating narcotic drugs

The Single Convention on Narcotic Drugs, 1961 is a United Nations treaty that controls activities of specific narcotic drugs and lays down a system of regulations for their medical and scientific uses; it also establishes the International Narcotics Control Board.

The International Narcotics Control Board (INCB) is an independent treaty body, one of the four treaty-mandated bodies under international drug control law.

<span class="mw-page-title-main">United Nations Commission on Narcotic Drugs</span> Central drug policy-making body of the UN System

The Commission on Narcotic Drugs (CND) is one of the functional commissions of the United Nations' Economic and Social Council (ECOSOC), and is the central drug policy-making body within the United Nations System. The CND also has important mandates under the three international drug control conventions, alongside the three other treaty-mandated bodies: United Nations Office on Drugs and Crime, World Health Organization, and International Narcotics Control Board.

<span class="mw-page-title-main">Shafer Commission</span> United States commission

The Shafer Commission, formally known as the National Commission on Marihuana and Drug Abuse, was appointed by U.S. President Richard Nixon in the early 1970s. Its chairman was former Pennsylvania Governor Raymond P. Shafer. The commission issued a report on its findings in 1972 that called for the decriminalization of marijuana possession in the United States. The report was ignored by the White House, but is an important document against prohibition.

<span class="mw-page-title-main">Ethan Nadelmann</span> American writer and campaigner for marijuanas legalization

Ethan A. Nadelmann is the founder of the Drug Policy Alliance, a New York City-based non-profit organization working to end the War on Drugs. He is a supporter of the legalization of marijuana in America.

A drug policy is the policy regarding the control and regulation of psychoactive substances, particularly those that are addictive or cause physical and mental dependence. While drug policies are generally implemented by governments, entities at all levels may have specific policies related to drugs.

<span class="mw-page-title-main">Drug liberalization</span> Process of reducing drug prohibition laws

Drug liberalization is a drug policy process of decriminalizing, legalizing, or repealing laws that prohibit the production, possession, sale, or use of prohibited drugs. Variations of drug liberalization include drug legalization, drug relegalization, and drug decriminalization. Proponents of drug liberalization may favor a regulatory regime for the production, marketing, and distribution of some or all currently illegal drugs in a manner analogous to that for alcohol, caffeine and tobacco.

Illicit drug use in Australia is the recreational use of prohibited drugs in Australia. Illicit drugs include illegal drugs, pharmaceutical drugs when used for non-medical purposes, and other substances used inappropriately. According to government and community organisations, the use and abuse, and the illegality, of illicit drugs is a social, health and legal issue that creates an annual illegal market estimated to be worth A$6.7 billion. Estimates made in 2022 place the figure at A$11.3 billion per year.

<span class="mw-page-title-main">Drug policy of Canada</span> Overview of the drug policy of Canada

Canada's drug regulations are measures of the Food and Drug Act and the Controlled Drugs and Substances Act. In relation to controlled and restricted drug products, the Controlled Drugs and Substances Act establishes eight schedules of drugs and new penalties for the possession, trafficking, exportation and production of controlled substances as defined by the Governor-in-Council. Drug policy of Canada has traditionally favoured punishment for the smallest of offences, but this convention was partially broken in 1996 with the passing of the Controlled Drugs and Substances Act.

<span class="mw-page-title-main">George Shultz</span> American politician (1920–2021)

George Pratt Shultz was an American economist, businessman, diplomat and statesman. He served in various positions under two different Republican presidents and is one of the only two persons to have held four different Cabinet-level posts, the other being Elliot Richardson. Shultz played a major role in shaping the foreign policy of the Ronald Reagan administration, and conservative foreign policy thought thereafter.

The Latin American Commission on Drugs and Democracy was a panel of Latin American leaders and intellectuals, co-chaired by former presidents Fernando Henrique Cardoso (Brazil), César Gaviria (Colombia) and Ernesto Zedillo (Mexico).

<span class="mw-page-title-main">Psychoactive drug</span> Chemical substance that alters nervous system function

A psychoactive drug, psychopharmaceutical, psychoactive agent, or psychotropic drug is a chemical substance that changes the function of the nervous system and results in alterations of perception, mood, cognition, and behavior.

<span class="mw-page-title-main">Drugs in the United States</span>

In the United States, the Federal Food, Drug, and Cosmetic Act defined the word "drug" as an "article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals" and those "(other than food) intended to affect the structure or any function of the body of man or other animals." Consistent with that definition, the U.S. separately defines narcotic drugs and controlled substances, which may include non-drugs, and explicitly excludes tobacco, caffeine and alcoholic beverages.

The list includes and details significant events that occurred in the global history of national-level implementations of, or changes made to, laws surrounding the use, sale, or production of the psychoactive drug cannabis.

References

  1. 1 2 3 "World Leaders Call for End to Criminalizing Drug Consumption" Archived 2016-11-30 at the Wayback Machine , The Costa Rica Star, November 28, 2016. Retrieved 2016-12-06.
  2. ↑ Shultz, George P.; Paul A. Volcker (11 June 2011). "A Real Debate About Drug Policy". The Wall Street Journal. Archived from the original on 13 August 2017. Retrieved 3 August 2017.
  3. ↑ Tharoor, Ishaan, "Report: The Global War on Drugs Has Failed. Is It Time to Legalize?", Time , June 03, 2011. Retrieved 2011-06-03.
  4. ↑ "Commission" page Archived 2011-05-29 at the Wayback Machine , GCDP webpage. Retrieved 2011-06-03.
  5. ↑ Latin American Initiative on Drugs and Democracy membership Archived 2011-05-04 at the Wayback Machine , LAIDD webpage. Retrieved 2011-06-03.
  6. ↑ "West Africa Commission on Drugs" Archived 2019-03-08 at the Wayback Machine , globalcommissionondrugs.org/wacd. Retrieved 2019-03-20.
  7. ↑ Shultz, George P. and Pedro Aspe, "The Failed War on Drugs" Archived 2018-01-01 at the Wayback Machine , New York Times op-ed, December 31, 2017. Retrieved 2018-01-01.
  8. ↑ Archived 2022-12-02 at the Wayback Machine , globalcommissionondrugs.org webpage. Retrieved 2019-04-13.
  9. ↑ Kwaśniewski, Aleksander, "Saying No to Costly Drug Laws" New York Times, May 10, 2012.
  10. ↑ "Dr. Gabor Maté: Obama Admin Should Heed Global Panel's Call to End 'Failed' U.S.-Led Drug War", Democracy Now!, June 6, 2011. Audio and transcript.
  11. ↑ Carter, Jimmy, "Call Off the Global Drug War" Archived 2017-03-07 at the Wayback Machine , The New York Times, June 16, 2011. Retrieved 2011-07-12.
  12. ↑ "Letters: Dispatches From the War on Drugs" Archived 2014-03-11 at the Wayback Machine , The New York Times, June 26, 2011. Retrieved 2011-07-12.
  13. ↑ "Serious Words" Archived 2011-06-29 at the Wayback Machine , The Brian Lehrer Show , WNYC, June 27, 2011. Audio archive only. Retrieved 2011-07-12.
  14. ↑ "Global drugs war strategy has failed - overhaul it" Archived 2012-03-15 at the Wayback Machine , The Tribune, June 27, 2011. Retrieved 2011-07-12.
  15. ↑ Hakim, Peter, "Rethinking US Drug Policy" Archived 2012-05-24 at the Wayback Machine , Política Exterior (Inter-American Dialogue), October 31, 2011. Retrieved 2011-11-25.
  16. ↑ Bio Archived 2011-11-17 at the Wayback Machine , Beckley Foundation webpage. Retrieved 2011-11-25.
  17. ↑ "Global Initiative" Archived 2012-01-26 at the Wayback Machine , Beckley Foundation webpage. Retrieved 2011-11-25.
  18. ↑ Beckford, Martin, "It's time to decriminalise drug use, say peers", The Telegraph , 20 March 2011. Retrieved 2011-11-25.
  19. ↑ "Background Papers" Archived 2011-11-25 at the Wayback Machine , GCDP webpage. Retrieved 2011-11-25.
  20. ↑ Taking Control: Summary Archived 2014-09-12 at the Wayback Machine , gcdpsummary2014.com, September 2014. Downloads of full report available in English, Spanish, French, Portuguese, and Russian.
  21. ↑ "New Report: World Leaders Call For Ending Criminalization of Drug Use and Possession and Responsible Legal Regulation of Psychoactive Substances" Archived 2014-09-13 at the Wayback Machine , globalcommissionondrugs.org, September 8, 2014.
  22. ↑ "Public Statement by the Global Commission on Drug Policy on UNGASS 2016", Press release, April 21, 2016. Retrieved 2016-04-25.
  23. ↑ Fassihi, Farnaz, "U.N. Conference on Drugs Ends Without Shift in Policy" Archived 2018-06-15 at the Wayback Machine , Wall Street Journal, April 22, 2016. Retrieved 2016-04-25.
  24. ↑ "Advancing Drug Policy Reform: 2016" Archived 2016-11-30 at the Wayback Machine , globalcommissionondrugs.org, 2016. Downloads available in English, Spanish, French, German, Russian, Portuguese, Chinese, and Arabic. Retrieved 2016-12-06.
  25. ↑ "The Opioid Crisis in North America" Archived 2018-01-18 at the Wayback Machine , globalcommissionondrugs.org, 2017.
  26. ↑ "The World Drug Perception Problem: Countering Prejudices About People Who Use Drugs" Archived 2018-01-18 at the Wayback Machine , globalcommissionondrugs.org, 2017.
  27. ↑ "Regulation: The Responsible Control of Drugs" Archived 2018-09-21 at the Wayback Machine , globalcommissionondrugs.org, 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.